Teva acquires Emalex Biosciences for up to $900m
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) today announced it has signed a definitive agreement to acquire Emalex ...
Tuesday, May 5, 2026
Tag: Teva
Teva Pharmaceuticals – TEVA: Abschied vom Generika-Geschäft! Was nun?
Strategische Neuausrichtung! Pullback-Setup bei der Teva-Aktie! Kommt der Bounce nach 7 roten Kerzen? Quartalszahlen erst im Mai! Teva Pharmaceuticals (TEVA) ...
Teva sees lower revenue and profit in 2026
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) ended 2025 with revenue of $17.3 billion, up 4% from $16.5 ...
Teva beats analysts on Q3, raises guidance
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has presented strong third quarter results and calmed investors. Despite concerns, ...
Teva jumps ahead of Q3 results
The share price of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) rose 8.1% last week on Wall Street, ...
Stanley Druckenmiller builds Teva position.
Famed US billionaire investor Stanley Druckenmiller's Duquesne Family Office has been buying shares of Teva Pharmaceutical Industries Ltd. (NYSE: ...
Analysts see huge upside in Teva
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) last week published its second quarter financial results in which it ...
Teva again raises profit guidance
Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) beat the analysts on profit in the second quarter of 2025 ...
Israeli institutional investors bet on Teva
The share price of Teva Pharmaceutical Industries Ltd. (NYSE: TEVA; TASE: TEVA) has been treading water recently as two ...
The first and only national digital and print magazine that connects individuals, families, and businesses to Fee-Only financial advisers, accountants, attorneys and college guidance counselors.